Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) SVP Emily Dreyer sold 14,025 shares of the firm’s stock in a transaction on Friday, March 7th. The stock was sold at an average price of $32.41, for a total value of $454,550.25. Following the completion of the transaction, the senior vice president now owns 27,645 shares in the company, valued at $895,974.45. This represents a 33.66 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Trupanion Stock Up 2.3 %
Shares of TRUP traded up $0.74 on Tuesday, hitting $33.20. The company’s stock had a trading volume of 586,401 shares, compared to its average volume of 641,189. The firm’s fifty day moving average price is $43.80 and its 200-day moving average price is $47.42. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39. Trupanion, Inc. has a fifty-two week low of $19.69 and a fifty-two week high of $57.90. The firm has a market capitalization of $1.41 billion, a price-to-earnings ratio of -144.35, a P/E/G ratio of 6.02 and a beta of 1.70.
Trupanion (NASDAQ:TRUP – Get Free Report) last announced its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.02). Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The company had revenue of $337.31 million during the quarter, compared to the consensus estimate of $335.41 million. On average, equities research analysts expect that Trupanion, Inc. will post 0.13 EPS for the current year.
Hedge Funds Weigh In On Trupanion
Wall Street Analysts Forecast Growth
TRUP has been the topic of a number of recent analyst reports. Stifel Nicolaus reduced their target price on Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a report on Thursday, February 20th. Piper Sandler cut their price target on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a research report on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $46.60.
Check Out Our Latest Report on TRUP
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
See Also
- Five stocks we like better than Trupanion
- Growth Stocks: What They Are, What They Are Not
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- How to Effectively Use the MarketBeat Ratings Screener
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- Industrial Products Stocks Investing
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.